Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females

Figure 2

WBC with methylated BRCA1 show similar epigenetic changes in both breast cancer cases and carriers (A) a heat map comparing the methylation status of a panel of 10 cancer-related genes in WBC from controls C, breast cancer BC, and carriers CR as determined using Human Breast Cancer EpiTect Methyl II Signature PCR Array. The red color represents values of +2.5 fold relative to controls (B) Comparison between quantitative analysis of methylation for the candidate genes in the studied cohort; Controls (n = 10), Breast cancer (n = 17) and Carriers (n = 9). Significant correlation; Chi square. Numbers represent p values. Error bars represent the mean ± SD.

Back to article page